CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 738 enrolled
Drug / intervention
3M CHG/IPA Prep C +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02203591
NCT02203591Phase 3Completed

Assessment of the Antimicrobial Efficacy of 3M CHG/IPA Preoperative Skin Preparation Against Resident Human Skin Flora on the Abdominal and Inguinal Regions

3M·interventional·Posted Jul 30, 2014·Updated Nov 23, 2020

In Brief

A Phase 3 clinical trial evaluating 3M CHG/IPA Prep C, 3M CHG/IPA Prep CH, and 2 other interventions for Bacterial Reduction Post-product Application. Completed, enrolled 738 participants across 1 site.

Detailed Summary

The objective of this study is to demonstrate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 30, 2014
Enrollment StartJul 1, 2014
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 11.9 years ago

Interventions

3M CHG/IPA Prep Cdrug

Apply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.

3M CHG/IPA Prep CHdrug

Apply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.

ChloraPrepdrug

Apply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.

Normal Salinedrug

Apply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.